Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezoleam vs Pyrazinamide for Elderly Drug-Sensitive Pulmonary Tuberculosis
ChiCTR2500106183Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of contezolid in pulmonary tuberculosis (TB) (2 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoint: Treatment success rate. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2500106183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106183.